SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT06649292 · RECRUITING
Trial details
- NCT number
- NCT06649292
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-22
- Primary completion
- 2027-09-20
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.